Advertisement

Topics

Genentech, Inc. Company Profile

13:37 EST 23rd January 2019 | BioPortfolio

Founded more than 35 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California.

Research
Genentech conducts basic and applied research in the areas of in Oncology, Immunology, Neuroscience, Metabolism, and Infectious Disease. Genentech's approximately 1,200 researchers and scientists and 135 postdocs consistently publish important papers in prestigious journals and are among the total citations.

Pipeline
Genentech's development pipeline continues to grow, with multiple promising projects in the following therapeutic focus areas: Oncology, Immunology, Neuroscience, Metabolism, and Infectious Disease. Genentech's clinical development pipeline includes monoclonal antibodies, small molecules, and antibody drug conjugates that address serious unmet medical needs.

Key Products
Since the company was founded in 1976, Genentech has focused its drug discovery efforts on medicines that address significant unmet medical needs. Today Genentech has multiple products on the market for serious or life-threatening medical conditions. In March 2009, Genentech became a member of the Roche Group, and Genentech now serves as the headquarters for all Roche pharmaceutical operations in the United States. Accordingly, the list below includes products, which were previously marketed as Roche products that are now being marketed by Genentech in the United States.

BIOONCOLOGY
Avastin® (bevacizumab)
Erivedge® (vismodegib)
Herceptin® (trastuzumab)
Kadcyla™ (ado-trastuzumab emtansine)
Perjeta® (pertuzumab)
Rituxan® (rituximab-BioOncology)
Tarceva® (erlotinib)
Xeloda® (capecitabine)
Zelboraf® (vemurafenib)

IMMUNOLOGY AND OPHTHALMOLOGY
Actemra® (tocilizumab)
Lucentis™ (ranibizumab injection)
Rituxan® (rituximab - Immunology)
Xolair® (omalizumab)

METABOLISM & PRIMARY CARE
Activase® (alteplase)
Cathflo Activase® (alteplase)
Nutropin AQ® (somatropin (rDNA origin) for injection)
TNKase® (tenecteplase)

VIROLOGY & SPECIALTY CARE
CellCept® (mycophenolate mofetil)
Pegasys® (peginterferon alfa-2a)
Pulmozyme® (dornase alfa)
Tamiflu® (oseltamivir phosphate)
Valcyte® (valganciclovir hydrochloride)

OTHER PRODUCTS
Anaprox® (naproxen sodium)
Boniva Injection® (ibandronate sodium)
Boniva Tablets® (ibandronate sodium)
Cytovene® (ganciclovir)
EC-Naprosyn® (naproxen)
Fuzeon® (enfuvirtide)
Invirase® (saquinavir mesylate)
Klonopin® (clonazepam)
Kytril Injection™ (granisetron HCL)
Kytril Tablets® (ganisetron HCL)
Naprosyn® (naproxen)
Rocephin® (ceftriaxone)
Roferon-A® (interferon alfa-2a)
Romazicon® (flumazenil)
Valium ® (diazepam)
Xenical® (orlistat)
Zenapax® (daclizumab)

Source: http://www.gene.com/medical-professionals/medicines

Location

1 DNA Way
South San Francisco
CA
94080
USA

Contact

Phone: (650) 225-1000
Fax: (650) 225-6000


News Articles [305 Associated News Articles listed on BioPortfolio]

Affimed signs innate cell antibody engager deal with Genentech

Affimed NV and Roche’s Genentech Inc. agreed to discover and conduct early- and late-stage research on innate immune cell--natural killer (NK) cell and T-cell--immunotherapies against certain Genent...

Genentech Gains Rights to Portfolio of NLRP3 Inhibitors through Acquisition of Jecure Therapeutics

SAN DIEGO–(BUSINESS WIRE)–Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, today announced a definitive agreeme...

Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy

Immunocore and the US biotech giant Genentech are building on their existing partnership to boost the clinical development of Immunocore’s immunotherapy for treating solid tumors. In the agreeme...

FDA Approves Genentech Flu Drug

The US Food and Drug Administration (FDA) has approved a new drug produced by Genentech to treat acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for...

Genentech Flu Drug Scores Another Late-Stage Win

With flu season fast approaching, Genentech has some good news for people who are at high risk of complications from the illness.

Genentech's juvenile idiopathic arthritis therapy wins FDA nod

Roche Holding unit Genentech's Actemra, or tocilizumab, was granted approval by the FDA as a treatment for patients age 2 and -More- 

STAT Plus: Former Genentech employees are arrested on charges they stole trade secrets

The allegations involving Genentech come as the race to develop and market biosimilars heats up.

Roche-Tochter Genentech übernimmt US-Biotechfirma Jecure

Basel (awp) - Die Roche-Tochter Genentech übernimmt das US-Biotechfirma Jecure. Damit erhält Genentech die vollen Rechte über das präklinische Portfolio mit NLRP3-Hemmern, wie beide Unternehmen am...

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Sterile water [Genentech, Inc.]

Sterile Water for Injection, USP

Xolair [Genentech, Inc.]

These highlights do not include all the information needed to use XOLAIR safely and effectively. See full prescribing information for XOLAIR. XOLAIR (omalizumab) injection, for subcutaneous useXOLAIR ...

Cellcept [Genentech, Inc.]

These highlights do not include all the information needed to use CELLCEPT safely and effectively. See full prescribing information for CELLCEPT CELLCEPT (mycophenolate mofetil) capsules, for oral use...

Fuzeon [Genentech, Inc.]

These highlights do not include all the information needed to use FUZEON safely and effectively. See full prescribing information for FUZEON. FUZEON (enfuvirtide) for Injection Initial U.S. Approval: ...

Pulmozyme [Genentech, Inc.]

These highlights do not include all the information needed to use PULMOZYME safely and effectively. See full prescribing information for PULMOZYME. PULMOZYME (dornase alfa) inhalation solution, for in...

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Genentech prospects gut and soil.

Genentech trade secrets theft highlights risk for biotechs.

Emicizumab for routine prophylaxis to prevent bleeding episodes in patients with hemophilia A.

Hemophilia A is an X-linked bleeding disorder caused by defects in the gene encoding factor VIII (FVIII). Routine prophylaxis with exogenous FVIII requires frequent intravenous injections. One of the ...

Long-acting intraocular delivery strategies for biological therapy of age-related macular degeneration.

As one of the leading causes of central vision loss in elderly population, worldwide cases of age-related macular degeneration (AMD) have seen a dramatic increase over the past several years. Treatmen...

Case 260.

History A 31-year-old woman with a history of bilateral orthotopic lung transplantation performed 10 months earlier for cystic fibrosis presented for a routine follow-up appointment, with her chief sy...

Clinical Trials [38 Associated Clinical Trials listed on BioPortfolio]

Mechanisms of Exacerbation of Asthma

The purpose of this study is to identify the causes of asthma that were not previously suspected, to better understand the effects of inhaled steroids on asthma and to identify new way to ...

Study of the Mechanisms of Asthma

The purpose of this study is to identify the causes of asthma that were not previously suspected, to better understand the effects of inhaled steroids on asthma and to identify new way to ...

A Study of GDC-0449 (Hedgehog Pathway Inhibitor) in Patients Treated With GDC-0449 in a Previous Genentech-Sponsored Phase I or II Cancer Study

This is a multicenter, open-label extension study. Patients receiving GDC-0449 in a Genentech-sponsored study who have completed the parent study or who continue to receive GDC-0449 at th...

An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

This is a multicenter, open-label extension study. Subjects who have received rhuMAb VEGF (Avastin) therapy in any Genentech-sponsored Phase I or Phase II cancer study and who did not sho...

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study

This is an open-label, multicenter, extension study. Patients who are receiving clinical benefit from atezolizumab monotherapy or atezolizumab in combination with other agent(s) or compara...

Companies [46 Associated Companies listed on BioPortfolio]

VaxGen Incorporated

VaxGen were formed to continue development of AIDSVAX in partnership with Genentech. In connection with our formation, Genentech licensed to us the technology necessary for completing development and ...

Genentech, Inc.

Founded more than 35 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening me...

Genentech

Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, commer...

Lpath

Lpath, Inc., headquartered in San Diego, California, is a theranostics company focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases. Lpath's lead produ...

ImmunoGen, Inc.

ImmunoGen, Inc. develops targeted anticancer therapeutics using its expertise in cancer biology, monoclonal antibodies and the creation and attachment of potent cell-killing agent...

More Information about "Genentech, Inc." on BioPortfolio

We have published hundreds of Genentech, Inc. news stories on BioPortfolio along with dozens of Genentech, Inc. Clinical Trials and PubMed Articles about Genentech, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genentech, Inc. Companies in our database. You can also find out about relevant Genentech, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record